All Relations between Diabetic Neuropathies and superior colliculus

Reference Sentence Publish Date Extraction Date Species
Andrea M Yeung, Jingtong Huang, Kevin T Nguyen, Nicole Y Xu, Lorenzo T Hughes, Brajesh K Agrawal, Niels Ejskjaer, David C Klonof. Spinal Cord Stimulation for Painful Diabetic Neuropathy. Journal of diabetes science and technology vol issue 2022 36384312 spinal cord stimulation (scs) technology has been recently approved by the us food and drug administration (fda) for painful diabetic neuropathy (pdn). 2022-11-17 2022-11-21 Not clear
Bryan C Hoelzer, Deborah Edgar, Shiao-Ping Lu, Rod S Taylo. Indirect Comparison of 10 kHz Spinal Cord Stimulation (SCS) versus Traditional Low-Frequency SCS for the Treatment of Painful Diabetic Neuropathy: A Systematic Review of Randomized Controlled Trials. Biomedicines vol 10 issue 10 2022 36289892 indirect comparison of 10 khz spinal cord stimulation (scs) versus traditional low-frequency scs for the treatment of painful diabetic neuropathy: a systematic review of randomized controlled trials. 2022-10-27 2022-11-01 Not clear
Bryan C Hoelzer, Deborah Edgar, Shiao-Ping Lu, Rod S Taylo. Indirect Comparison of 10 kHz Spinal Cord Stimulation (SCS) versus Traditional Low-Frequency SCS for the Treatment of Painful Diabetic Neuropathy: A Systematic Review of Randomized Controlled Trials. Biomedicines vol 10 issue 10 2022 36289892 spinal cord stimulation (scs) is increasingly used to treat painful diabetic neuropathy (pdn). 2022-10-27 2022-11-01 Not clear
Rui V Duarte, Sarah Nevitt, Sue Copley, Michelle Maden, Cecile C de Vos, Rod S Taylor, Sam Eldab. Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes care vol 45 issue 10 2022 36150057 different waveforms of spinal cord stimulation (scs) have now been evaluated for the management of painful diabetic neuropathy (pdn). 2022-09-23 2022-09-29 Not clear
Erika A Petersen, Thomas G Stauss, James A Scowcroft, Elizabeth S Brooks, Judith L White, Shawn M Sills, Kasra Amirdelfan, Maged N Guirguis, Jijun Xu, Cong Yu, Ali Nairizi, Denis G Patterson, Kostandinos C Tsoulfas, Michael J Creamer, Vincent Galan, Richard H Bundschu, Neel D Mehta, Dawood Sayed, Shivanand P Lad, David J DiBenedetto, Khalid A Sethi, Johnathan H Goree, Matthew T Bennett, Nathan J Harrison, Atef F Israel, Paul Chang, Paul W Wu, Charles E Argoff, Christian E Nasr, Rod S Taylor, David L Caraway, Nagy A Mekhai. High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled Trial. Mayo Clinic proceedings. Innovations, quality & outcomes vol 6 issue 4 2022 35814185 to evaluate high-frequency (10-khz) spinal cord stimulation (scs) treatment in refractory painful diabetic neuropathy. 2022-07-11 2022-07-19 Not clear
Vuong M Pham, Nitish Thako. Insulin enhances neurite extension and myelination of diabetic neuropathy neurons. The Korean journal of pain vol 35 issue 2 2022 35354679 the authors established an in vitro model of diabetic neuropathy based on the culture system of primary neurons and schwann cells (scs) to mimic similar symptoms observed in in vivo models of this complication, such as impaired neurite extension and impaired myelination. 2022-03-31 2022-04-14 Not clear
Rui V Duarte, Sarah Nevitt, Michelle Maden, Kaare Meier, Rod S Taylor, Sam Eldabe, Cecile C de Vo. Spinal cord stimulation for the management of painful diabetic neuropathy: a systematic review and meta-analysis of individual patient and aggregate data. Pain vol 162 issue 11 2021 33872236 spinal cord stimulation (scs) has been suggested as a treatment option for patients with painful diabetic neuropathy (pdn). 2021-10-25 2022-01-13 Not clear
D Fontain. Spinal cord stimulation for neuropathic pain. Revue neurologique vol 177 issue 7 2021 34384626 two rcts confirmed scs efficacy in painful diabetic neuropathy in comparison with cmm. 2021-09-14 2022-01-13 Not clear
N\\xc3\\xa1dia P Gon\\xc3\\xa7alves, Yan Yan, Maj Ulrichsen, Morten T Ven\\xc3\\xb8, Ebbe T Poulsen, Jan J Enghild, J\\xc3\\xb8rgen Kjems, Christian B V\\xc3\\xa6gte. Modulation of Small RNA Signatures in Schwann-Cell-Derived Extracellular Vesicles by the p75 Neurotrophin Receptor and Sortilin. Biomedicines vol 8 issue 11 2020 33114403 schwann cells (scs) are the main glial cells of the peripheral nervous system (pns) and are known to be involved in various pathophysiological processes, such as diabetic neuropathy and nerve regeneration, through neurotrophin signaling. 2020-11-28 2022-01-13 Not clear
Kuruvanthe S Rachana, Mallahalli S Manu, Gopal M Advira. Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy. Diabetes & metabolic syndrome vol 12 issue 4 2018 29602762 earlier reports from our laboratory have provided the insights of insulin and its receptor in scs during diabetic neuropathy. 2018-11-08 2022-01-13 Not clear
Kuruvanthe S Rachana, Mallahalli S Manu, Gopal M Advira. Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy. Diabetes & metabolic syndrome vol 12 issue 4 2018 29602762 since, lipoprotein lipase (lpl) provides the lipid for myelin sheath by hydrolysing the triglyceride rich lipoproteins, and also helps in the uptake of lipids by the schwann cells (scs) for its utilization, lpl is considered as the important factor in the regeneration of myelin sheath during diabetic neuropathy. 2018-11-08 2022-01-13 Not clear
Kuruvanthe S Rachana, Mallahalli S Manu, Gopal M Advira. Insulin-induced upregulation of lipoprotein lipase in Schwann cells during diabetic peripheral neuropathy. Diabetes & metabolic syndrome vol 12 issue 4 2018 29602762 in order to evaluate the long term effect of insulin on lipid metabolism during diabetic neuropathy, in this study, we analyzed the expression of lpl in scs under normal, high glucose and insulin treated conditions. 2018-11-08 2022-01-13 Not clear
Rui V Duarte, Lazaros Andronis, Mathieu W P M Lenders, Cecile C de Vo. Quality of life increases in patients with painful diabetic neuropathy following treatment with spinal cord stimulation. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation vol 25 issue 7 2017 26694963 this study aims to explore the changes in pain intensity and quality of life (qol) experienced by patients with painful diabetic neuropathy (pdn) treated with spinal cord stimulation (scs) and conventional medical practice (cmp). 2017-02-22 2022-01-12 Not clear
Liang Zhang, Cuijuan Yu, Francisco E Vasquez, Nadya Galeva, Isaac Onyango, Russell H Swerdlow, Rick T Dobrowsk. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. Journal of proteome research vol 9 issue 1 2010 19905032 although schwann cells (scs) also undergo substantial degeneration in diabetic neuropathy, the effect of hyperglycemia on the sc mitochondrial proteome and mitochondrial function has not been examined. 2010-03-30 2022-01-12 Not clear
Cecile C de Vos, Vinayakrishnan Rajan, Wiendelt Steenbergen, Hans E van der Aa, Hendrik P J Buschma. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. Journal of diabetes and its complications vol 23 issue 1 2009 18413161 the primary objectives of this study were to evaluate the effect and safety of scs for treatment of pain and the effects on microcirculatory blood flow in the affected areas in patients with refractory peripheral diabetic neuropathy. 2009-02-04 2022-01-12 Not clear
Cecile C de Vos, Vinayakrishnan Rajan, Wiendelt Steenbergen, Hans E van der Aa, Hendrik P J Buschma. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. Journal of diabetes and its complications vol 23 issue 1 2009 18413161 spinal cord stimulation (scs) has been shown effective as a therapy for different chronic painful conditions, but the effectiveness of this treatment for pain as a result of peripheral diabetic neuropathy is not well established. 2009-02-04 2022-01-12 Not clear
Cuijuan Yu, Shefali Rouen, Rick T Dobrowsk. Hyperglycemia and downregulation of caveolin-1 enhance neuregulin-induced demyelination. Glia vol 56 issue 8 2008 18338795 as myelinated scs undergo substantial degeneration in diabetic neuropathy, we used myelinated sc/drg neuron co-cultures to determine if hyperglycemia and changes in cav-1 expression could enhance nrg-induced demyelination. 2008-07-10 2022-01-12 Not clear
Michiru Fukunaga, Satoshi Miyata, Satomi Higo, Yasuhiro Hamada, Shigemitsu Ueyama, Masato Kasug. Methylglyoxal induces apoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells. Annals of the New York Academy of Sciences vol 1043 issue 2005 16037234 these results suggest a possible contribution of glucose-derived mg to the development of diabetic neuropathy by injuring the cellular constituent of the peripheral nerve system, such as scs, in the hyperglycemic milieu. 2005-10-27 2022-01-12 Not clear
Michiru Fukunaga, Satoshi Miyata, Bing Fen Liu, Hiroyuki Miyazaki, Yushi Hirota, Satomi Higo, Yasuhiro Hamada, Shigemitsu Ueyama, Masato Kasug. Methylglyoxal induces apoptosis through activation of p38 MAPK in rat Schwann cells. Biochemical and biophysical research communications vol 320 issue 3 2004 15240103 we examined whether mg was capable of inducing apoptosis in schwann cells (scs), since recent studies have suggested a potential involvement of apoptotic cell death in the development of diabetic neuropathy. 2004-08-26 2022-01-12 Not clear
C L Delaney, J W Russell, H L Cheng, E L Feldma. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. Journal of neuropathology and experimental neurology vol 60 issue 2 2001 11273003 in the current study, 2 model systems are used to study the mechanism of sc damage in diabetic neuropathy: the streptozotocin (stz)-treated diabetic rat and cultures of purified scs in vitro. 2001-03-29 2022-01-11 Not clear
Page: 
1   2